Targeted and heat-triggered doxorubicin delivery to tumors by dual targeted cationic thermosensitive liposomes

Journal of Controlled Release

Volumn 195, Issue , 2014, Pages 37-48

  Dicheva, Bilyana M ^a   Ten Hagen, Timo L M ^a   Schipper, Debby ^a   Seynhaeve, Ann L B ^a   Van Rhoon, Gerard C ^a   Eggermont, Alexander M M ^a,b   Koning, Gerben A ^a  

^a ERASMUS MC CANCER INSTITUTE   (Netherlands)

^b INSTITUT GUSTAVE ROUSSY   (France)

Author keywords

Cancer chemotherapy; Cationic thermosensitive liposomes; Cytotoxicity; Hyperthermia; Triggered drug release

Indexed keywords

CANCER CHEMOTHERAPY; DOXORUBICIN; HYPERTHERMIA; THERMOSENSITIVE LIPOSOMES; TRIGGERED DRUG RELEASE;

CYTOTOXICITY;

CATION; DOXORUBICIN; LIPOSOME; NANOCARRIER; ANTINEOPLASTIC ANTIBIOTIC; MACROGOL DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER TRANSPLANTATION; COMPARATIVE STUDY; CONFOCAL MICROSCOPY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; ENCAPSULATION; ENDOTHELIUM CELL; HEAT SENSITIVITY; HUMAN; HUMAN CELL; HYPERTHERMIA; INTERNALIZATION; LIGHT SCATTERING; LIPID BILAYER; LYSOSOME; MELANOMA; MELANOMA CELL LINE; MOUSE; NONHUMAN; PARTICLE SIZE; SKINFOLD; TIMED DRUG RELEASE; TUMOR CELL; TUMOR VASCULARIZATION; UMBILICAL VEIN ENDOTHELIAL CELL; ANALOGS AND DERIVATIVES; ANIMAL; C57BL MOUSE; DRUG EFFECTS; HEAT; METABOLISM; NEOPLASMS; TUMOR CELL LINE;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; CELL LINE, TUMOR; DOXORUBICIN; HOT TEMPERATURE; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MICE, INBRED C57BL; MICROSCOPY, CONFOCAL; NEOPLASMS; POLYETHYLENE GLYCOLS;

EID: 84908592600     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2014.07.058     Document Type: Article

References (50)

1. T.M. Allen, C. Hansen, F. Martin, C. Redemann, and A. Yau-Young Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo Biochim. Biophys. Acta 1066 1 1991 Jul 1 29 36
2. A. Gabizon, H. Shmeeda, and Y. Barenholz Pharmacokinetics of pegylated liposomal doxorubicin: review of animal and human studies Clin. Pharmacokinet. 42 5 2003 419 436
3. A.A. Gabizon Selective tumor localization and improved therapeutic index of anthracyclines encapsulated in long-circulating liposomes Cancer Res. 52 4 1992 Feb 15 891 896
4. G.A. Koning, and G.C. Krijger Targeted multifunctional lipid-based nanocarriers for image-guided drug delivery Anticancer Agents Med. Chem. 7 4 2007 Jul 425 440
5. T.M. Allen, and P.R. Cullis Drug delivery systems: entering the mainstream Science 303 5665 2004 Mar 19 1818 1822
6. I. Judson, J.A. Radford, M. Harris, J.Y. Blay, Q. van Hoesel, and A. le Cesne Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL/CAELYX) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma Group Eur. J. Cancer 37 7 2001 May 870 877
7. D.W. Northfelt, B.J. Dezube, J.A. Thommes, B.J. Miller, M.A. Fischl, and A. Friedman-Kien Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial J. Clin. Oncol. 16 7 1998 Jul 2445 2451
8. M.E. O'Brien, N. Wigler, M. Inbar, R. Rosso, E. Grischke, and A. Santoro Reduced cardiotoxicity and comparable efficacy in a phase III trial of pegylated liposomal doxorubicin HCl (CAELYX/Doxil) versus conventional doxorubicin for first-line treatment of metastatic breast cancer Ann. Oncol. 15 3 2004 Mar 440 449
9. A.L. Seynhaeve, B.M. Dicheva, S. Hoving, G.A. Koning, and T.L. Ten Hagen Intact Doxil is taken up intracellularly and released doxorubicin sequesters in the lysosome: evaluated by in vitro/in vivo live cell imaging J. Control. Release 172 1 2013 Sep 4 330 340
10. A.L. Seynhaeve, S. Hoving, D. Schipper, C.E. Vermeulen, G. de Wiel-Ambagtsheer, and S.T. van Tiel Tumor necrosis factor alpha mediates homogeneous distribution of liposomes in murine melanoma that contributes to a better tumor response Cancer Res. 67 19 2007 Oct 1 9455 9462
11. K.M. Laginha, S. Verwoert, G.J. Charrois, and T.M. Allen Determination of doxorubicin levels in whole tumor and tumor nuclei in murine breast cancer tumors Clin. Cancer Res. 11 19 Pt 1 2005 Oct 1 6944 6949
12. R.B. Campbell, B. Ying, G.M. Kuesters, and R. Hemphill Fighting cancer: from the bench to bedside using second generation cationic liposomal therapeutics J. Pharm. Sci. 98 2 2009 Feb 411 429
13. A. Sckell, N. Safabakhsh, M. Dellian, and R.K. Jain Primary tumor size-dependent inhibition of angiogenesis at a secondary site: an intravital microscopic study in mice Cancer Res. 58 24 1998 Dec 15 5866 5869
14. G. Thurston, J.W. McLean, M. Rizen, P. Baluk, A. Haskell, and T.J. Murphy Cationic liposomes target angiogenic endothelial cells in tumors and chronic inflammation in mice J. Clin. Invest. 101 7 1998 Apr 1 1401 1413
15. K.T. Al-Jamal, W.T. Al-Jamal, J.T. Wang, N. Rubio, J. Buddle, and D. Gathercole Cationic poly-l-lysine dendrimer complexes doxorubicin and delays tumor growth in vitro and in vivo ACS Nano 7 3 2013 Mar 26 1905 1917
16. R.K. Jain Vascular and interstitial barriers to delivery of therapeutic agents in tumors Cancer Metastasis Rev. 9 3 1990 Nov 253 266
17. R.B. Campbell, D. Fukumura, E.B. Brown, L.M. Mazzola, Y. Izumi, and R.K. Jain Cationic charge determines the distribution of liposomes between the vascular and extravascular compartments of tumors Cancer Res. 62 23 2002 Dec 1 6831 6836
18. S. Krasnici, A. Werner, M.E. Eichhorn, M. Schmitt-Sody, S.A. Pahernik, and B. Sauer Effect of the surface charge of liposomes on their uptake by angiogenic tumor vessels Int. J. Cancer 105 4 2003 Jul 1 561 567
19. A. Abu-Lila, T. Suzuki, Y. Doi, T. Ishida, and H. Kiwada Oxaliplatin targeting to angiogenic vessels by PEGylated cationic liposomes suppresses the angiogenesis in a dorsal air sac mouse model J. Control. Release 134 1 2009 Feb 20 18 25
20. B.M. Dicheva, T.L. ten Hagen, L. Li, D. Schipper, A.L. Seynhaeve, and G.C. van Rhoon Cationic thermosensitive liposomes: a novel dual targeted heat-triggered drug delivery approach for endothelial and tumor cells Nano Lett. 13 6 2013 Jun 12 2324 2331
21. M. de Smet, S. Langereis, S. van den Bosch, and H. Grull Temperature-sensitive liposomes for doxorubicin delivery under MRI guidance J. Control. Release 143 1 2010 Apr 2 120 127
22. G. Kong, R.D. Braun, and M.W. Dewhirst Characterization of the effect of hyperthermia on nanoparticle extravasation from tumor vasculature Cancer Res. 61 7 2001 Apr 1 3027 3032
23. L. Li, T.L. Ten Hagen, M. Hossann, R. Suss, G.C. van Rhoon, and A.M. Eggermont Mild hyperthermia triggered doxorubicin release from optimized stealth thermosensitive liposomes improves intratumoral drug delivery and efficacy J. Control. Release 168 2 2013 Mar 21 142 150
24. L. Li, T.L. ten Hagen, D. Schipper, T.M. Wijnberg, G.C. van Rhoon, and A.M. Eggermont Triggered content release from optimized stealth thermosensitive liposomes using mild hyperthermia J. Control. Release 143 2 2010 Apr 19 274 279
25. M.R. Dreher, W. Liu, C.R. Michelich, M.W. Dewhirst, and A. Chilkoti Thermal cycling enhances the accumulation of a temperature-sensitive biopolymer in solid tumors Cancer Res. 67 9 2007 May 1 4418 4424
26. G. Kong, R.D. Braun, and M.W. Dewhirst Hyperthermia enables tumor-specific nanoparticle delivery: effect of particle size Cancer Res. 60 16 2000 Aug 15 4440 4445
27. L. Li, T.L. ten Hagen, M. Bolkestein, A. Gasselhuber, J. Yatvin, and G.C. van Rhoon Improved intratumoral nanoparticle extravasation and penetration by mild hyperthermia J. Control. Release 167 2 2013 Apr 28 130 137
28. M.W. Dewhirst, C.D. Landon, C.L. Hofmann, and P.R. Stauffer Novel approaches to treatment of hepatocellular carcinoma and hepatic metastases using thermal ablation and thermosensitive liposomes Surg. Oncol. Clin. N. Am. 22 3 2013 Jul 545 561
29. R.R. Sawant, and V.P. Torchilin Challenges in development of targeted liposomal therapeutics AAPS J. 14 2 2012 Jun 303 315
30. H. Grull, and S. Langereis Hyperthermia-triggered drug delivery from temperature-sensitive liposomes using MRI-guided high intensity focused ultrasound J. Control. Release 161 2 2013 Jul 20 317 327
31. Z.S. Al-Ahmady, W.T. Al-Jamal, J.V. Bossche, T.T. Bui, A.F. Drake, and A.J. Mason Lipid-peptide vesicle nanoscale hybrids for triggered drug release by mild hyperthermia in vitro and in vivo ACS Nano 6 10 2012 Oct 23 9335 9346
32. D. Needham, G. Anyarambhatla, G. Kong, and M.W. Dewhirst A new temperature-sensitive liposome for use with mild hyperthermia: characterization and testing in a human tumor xenograft model Cancer Res. 60 5 2000 Mar 1 1197 1201
33. M.B. Yatvin, J.N. Weinstein, W.H. Dennis, and R. Blumenthal Design of liposomes for enhanced local release of drugs by hyperthermia Science 202 4374 1978 Dec 22 1290 1293
34. M. Hossann, M. Wiggenhorn, A. Schwerdt, K. Wachholz, N. Teichert, and H. Eibl In vitro stability and content release properties of phosphatidylglyceroglycerol containing thermosensitive liposomes Biochim. Biophys. Acta 1768 10 2007 Oct 2491 2499
35. G. Rouser, S. Fkeischer, and A. Yamamoto Two dimensional then layer chromatographic separation of polar lipids and determination of phospholipids by phosphorus analysis of spots Lipids 5 5 1970 May 494 496
36. G. Haran, R. Cohen, L.K. Bar, and Y. Barenholz Transmembrane ammonium sulfate gradients in liposomes produce efficient and stable entrapment of amphipathic weak bases Biochim. Biophys. Acta 1151 2 1993 Sep 19 201 215
37. T.M. Allen, and P.R. Cullis Liposomal drug delivery systems: from concept to clinical applications Adv. Drug Deliv. Rev. 65 1 2013 Jan 36 48
38. K.J. Harrington, S. Mohammadtaghi, P.S. Uster, D. Glass, A.M. Peters, and R.G. Vile Effective targeting of solid tumors in patients with locally advanced cancers by radiolabeled pegylated liposomes Clin. Cancer Res. 7 2 2001 Feb 243 254
39. S.K. Huang, P.R. Stauffer, K. Hong, J.W. Guo, T.L. Phillips, and A. Huang Liposomes and hyperthermia in mice: increased tumor uptake and therapeutic efficacy of doxorubicin in sterically stabilized liposomes Cancer Res. 54 8 1994 Apr 15 2186 2191
40. A.A. Manzoor, L.H. Lindner, C.D. Landon, J.Y. Park, A.J. Simnick, and M.R. Dreher Overcoming limitations in nanoparticle drug delivery: triggered, intravascular release to improve drug penetration into tumors Cancer Res. 72 21 2012 Nov 1 5566 5575
41. R.T. Poon, and N. Borys Lyso-thermosensitive liposomal doxorubicin: a novel approach to enhance efficacy of thermal ablation of liver cancer Expert. Opin. Pharmacother. 10 2 2009 Feb 333 343
42. G.A. Koning, A.M. Eggermont, L.H. Lindner, and T.L. ten Hagen Hyperthermia and thermosensitive liposomes for improved delivery of chemotherapeutic drugs to solid tumors Pharm. Res. 27 8 2010 Aug 1750 1754
43. P. Swietach, A. Hulikova, S. Patiar, R.D. Vaughan-Jones, and A.L. Harris Importance of intracellular pH in determining the uptake and efficacy of the weakly basic chemotherapeutic drug, doxorubicin PLoS ONE 7 4 2012 e35949
44. M.J. Kirchmeier, T. Ishida, J. Chevrette, and T.M. Allen Correlations between the rate of intracellular release of endocytosed liposomal doxorubicin and cytotoxicity as determined by a new assay J. Liposome Res. 11 1 2001 15 29
45. J.E. Adrian, H.W. Morselt, R. Suss, S. Barnert, J.W. Kok, and S.A. Asgeirsdottir Targeted SAINT-O-Somes for improved intracellular delivery of siRNA and cytotoxic drugs into endothelial cells J. Control. Release 144 3 2010 Jun 15 341 349
46. S. Simoes, J.N. Moreira, C. Fonseca, N. Duzgunes, and M.C. de Lima On the formulation of pH-sensitive liposomes with long circulation times Adv. Drug Deliv. Rev. 56 7 2004 Apr 23 947 965
47. B.M. Dicheva, and G.A. Koning Targeted thermosensitive liposomes: an attractive novel approach for increased drug delivery to solid tumors Expert Opin. Drug Deliv. 11 1 2014 Jan 83 100
48. M.E. Eichhorn, I. Ischenko, S. Luedemann, S. Strieth, A. Papyan, and A. Werner Vascular targeting by EndoTAG-1 enhances therapeutic efficacy of conventional chemotherapy in lung and pancreatic cancer Int. J. Cancer 126 5 2010 Mar 1 1235 1245
49. B.M. Dicheva, T.L. ten Hagen, L. Li, D. Schipper, A.L. Seynhaeve, and G.C. van Rhoon Cationic thermosensitive liposomes: a novel dual targeted heat-triggered drug delivery approach for endothelial and tumor cells Nano Lett. 13 6 2013 Jun 12 2324 2331
50. R. Kunstfeld, G. Wickenhauser, U. Michaelis, M. Teifel, W. Umek, and K. Naujoks Paclitaxel encapsulated in cationic liposomes diminishes tumor angiogenesis and melanoma growth in a "humanized" SCID mouse model J. Invest. Dermatol. 120 3 2003 Mar 476 482